FDA Enforcement
Class II
Terminated
Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.
Recall: Z-0606-2018
·
Reported February 21, 2018
Enforcement
- Recall Number
- Z-0606-2018
- Event ID
- 78731
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Gibson Laboratories LLC
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- February 21, 2018
- Initiation Date
- January 20, 2017
- Classification Date
- February 13, 2018
- Termination Date
- February 20, 2018
- Address
- 1040 Manchester St, Lexington, KY, 40508-2422, United States
Description
Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.
Reason
The firm information that the product was reporting false positive results
Code Info
Lot # 5072543 Exp Date 03/12/2021; UDI : 10634853000039.
Distribution
Distributed to the states of AL, AZ & MS.
Quantity
10/1 mL vials